ATRC - AtriCure Medical Long-Term Liabilities to Capital

Symbol and logo of brand AtriCure Medical (ATRC)

AtriCure, Inc. (ATRC) maintains its leadership in surgical atrial fibrillation ablation through patent protection and FDA recognition, offering benchmark radiofrequency clamps. The business relies on the training of ablation specialists and the advancement of evidence-based medicine in cardiac surgery. This price chart illustrating trading dynamics reflects the 0.14 indicator. Stable cash flow is secured by leadership in cryoablation, although the share price currently prices in high expectations.

AtriCure Corp (ATRC): Long-Term Debt to Capital from 07/04/2022 to 10/28/2026

Comprehensive metric breakdowns and analytics for AtriCure, Inc. (ATRC)

- price and consensus price forecast:
Stock Quotes AtriCure Inc|ATRC - Analyst Consensus Forecast
- market capitalization data:
Market Value AtriCure, Inc.|ATRC - Enterprise Value
- book capitalization data:
Equity per Share AtriCure|ATRC - Book Capitalization|Market Capitalization to Book Value atricure.com|ATRC - Company Total Assets
- debt and liquidity data:
Total Debt to Equity Ratio AtriCure, Inc.|ATRC - Long-Term Debt to Capital|Short-Term Debt to Capital atricure.com|ATRC - Company Debts|Debt to Book Capitalization Ratio AtriCure, Inc.|ATRC - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings AtriCure
Comprehensive company analysis:ATRC AtriCure Inc
Core merchandise of AtriCure, Inc.

Institutional capital assesses the attractiveness of AtriCure, Inc. (ATRC) through the balance between financial leverage and the expansion rate of cryoablation technologies. Analyzing the ratio of long-term debt to equity allows for a comparison of loans with maturities exceeding one year against capital, determining how aggressively the scaling of the surgical ecosystem is being financed, which confirms the asset's resilience during active growth.

Competitor analysis

Long-Term Debt to Equity Ratio Intuitive Surgical, Inc.|Danaher Corp - Long-Term Debt to Capital|Long-Term Liabilities to Capital Becton Dickinson & Company (BDX)|STE - Long-Term Debt to Capital|Long-Term Debt to Capital Ratio westpharma.com WST|Long-Term Debt to Capital BAX (Baxter)|MASI - Ratio of Long-Term Indebtedness to Capital|STVN (Stevanato) - Long-Term Debt to Capital|Teleflex Corp (TFX) - Long-Term Debt to Equity Ratio|MMSI (Merit Medical Systems) - Long-Term Debt to Capital|Long-Term Debt to Capital NVST|Long-Term Debt to Equity ICU Medical (ICUI)|Long-Term Debt to Equity Dentsply Sirona Inc XRAY|Long-Term Debt to Equity Ratio LeMaitre|Long-Term Debt to Capital Coefficient STAAR Surgical Co STAA|Long-Term Debt to Capital NAGE (ChromaDex Corp.)|ZIMV: Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Equity AngioDynamics|CERS (Cerus Corp.) - Long-Term Debt to Capital Ratio|TKNO: Long-Term Debt to Equity|Ratio of Long-Term Indebtedness to Capital Monogram Orthopedics Inc. (MGRM)|Long-Term Debt to Equity Ratio Sharps Technology, Inc.|Long-Term Loans to Capital Ratio INFU (infusystem.com)|Long-Term Debt to Equity Utah Medical Products, Inc.|KRMD - Long-Term Debt to Capital Coefficient|Nyxoah, S.A. - Long-Term Debt to Equity Ratio|MBOT: Long-Term Debt to Capital|PDEX (Pro-Dex, Inc.) - Long-Term Debt to Equity|zentek.com (ZTEK) - Long-Term Debt to Equity Ratio|Long-Term Debt to Capital ELUT (Elutia)|Long-Term Liabilities to Capital MLSS|Long-Term Debt to Equity NEXGEL, Inc NXGL|Long-Term Debt to Capital Ratio retractable.com RVP|Long-Term Debt to Equity Ratio Harvard Bioscience, Inc. (HBIO)|femasys.com - Long-Term Loans to Capital Ratio|Long-Term Debt to Equity MHUA (Meihua Medical)|POAI - Ratio of Long-Term Indebtedness to Capital|CJMB: Long-Term Debt to Capital|Long-Term Debt to Capital Atrion Corporation Inc.|NeuroMetrix, Inc. (NURO) - Long-Term Debt to Equity Ratio